In addition, we identified several genes related to the γ-secretase machinery (e.g., NOTCH1, APP, ITM2B, APH1A and CD44) a key component of the Notch signaling pathway and target of novel therapies that aim to disrupt cancer stem cell signaling44 (Fig. 2d). The gene discussed is ITM2B; the disease is cancer.